Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05339958 · ClinicalTrials.gov registry record · NA
Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair
A NA study, sponsored by Nutraceutical Wellness.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT05339958: Completed NA study, sponsored by Nutraceutical Wellness.
NCT05339958 is a NA study that has completed, run by Nutraceutical Wellness. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05339958, a NA study, has completed, sponsored by Nutraceutical Wellness.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The objective of this study is to assess the effectiveness and safety of a novel dietary supplement containing botanical ingredients for hair thinning in men over the course of six months of continuous daily usage.
Primary Outcome
Changes in terminal hair counts as measured by photorichogram
Interventions
- DIETARY_SUPPLEMENT Nutrafol® Men Hair Growth Nutraceutical
- OTHER Placebo Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2023-04-05 |
| Phase | NA |
What the finished NCT05339958 record still lists
NCT05339958 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 2 interventions - of which Nutrafol® Men Hair Growth Nutraceutical is the first listed.
NCT05339958 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05339958 about?
NCT05339958 is a clinical study titled "Nutraceutical Supplement With Standardized Botanicals in Males With Thinning Hair". The objective of this study is to assess the effectiveness and safety of a novel dietary supplement containing botanical ingredients for hair thinning in men over the course of six months of continuous daily usage.
What is the current status of trial NCT05339958?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2021-07-19. Estimated completion is 2023-04-05.
What interventions are being tested in trial NCT05339958?
The interventions under investigation include: Nutrafol® Men Hair Growth Nutraceutical (DIETARY_SUPPLEMENT), Placebo Supplement (OTHER).
Who is sponsoring clinical trial NCT05339958?
This trial is sponsored by Nutraceutical Wellness, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05339958's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI